STOCK TITAN
  1. Home
  2. Sec-filings
  3. CYRX
  4. [Form 4] Cryoport, Inc. Insider Trading Activity

Cryoport (CYRX) tech chief exercises 35,000 options and sells shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cryoport, Inc.’s Chief Digital and Tech Officer, Edward J. Zecchini, reported a paired option exercise and share sale over two days. He exercised stock options covering 35,000 shares of common stock at an exercise price of $4.80 per share and sold 35,000 shares of common stock in open-market transactions.

The sales occurred at weighted average prices of about $15.23 on June 10, 2026 and $14.47 on June 11, 2026, with trades executed in narrow price ranges as disclosed. Following these transactions, he directly holds 109,719 shares of Cryoport common stock, and the option position referenced in this filing has been fully exercised.

Positive

  • None.

Negative

  • None.

Insights

Routine option exercise and matched share sale with holdings retained.

Edward J. Zecchini, Chief Digital and Tech Officer of Cryoport, exercised stock options for 35,000 shares at $4.80 and sold an equal number of shares around $14.47–$15.23. This is a classic exercise-and-sell pattern converting options into cash.

After the transactions, he continues to hold 109,719 shares directly, indicating a remaining equity stake. The filing shows no remaining derivative position from the exercised options. Based on the data provided, this appears to be a routine liquidity event rather than a transformational change in ownership.

Insider ZECCHINI EDWARD J
Role Chief Digital and Tech Officer
Sold 35,000 shs ($508K)
Type Security Shares Price Value
Exercise Stock Option (right to buy) 33,600 $0.00 --
Exercise Common Stock 33,600 $4.80 $161K
Sale Common Stock 33,600 $14.4714 $486K
Exercise Stock Option (right to buy) 1,400 $0.00 --
Exercise Common Stock 1,400 $4.80 $7K
Sale Common Stock 1,400 $15.2314 $21K
Holdings After Transaction: Stock Option (right to buy) — 0 shares (Direct, null); Common Stock — 143,319 shares (Direct, null)
Footnotes (1)
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.20 to $15.26, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.33 to $14.615, inclusive. 1/12 of options vested on the 23rd of each month for twelve months beginning July 23, 2017.
Shares sold 35,000 shares Open-market sales on June 10–11, 2026
Sale price June 10 $15.2314 per share Weighted average sale price on June 10, 2026
Sale price June 11 $14.4714 per share Weighted average sale price on June 11, 2026
Option exercise price $4.80 per share Exercise price of stock options converted to common
Options exercised 35,000 shares Stock options exercised and fully converted
Shares held after 109,719 shares Direct common stock holdings following transactions
Option expiration June 23, 2027 Original expiration date of exercised options
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)" with underlying common stock shares..."
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security" for code M entries..."
open-market sale financial
"transaction_action: "open-market sale" for common stock transactions coded S..."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ZECCHINI EDWARD J
(Last)(First)(Middle)
C/O CRYOPORT INC.
112 WESTWOOD PLACE, SUITE 350
(Street)
BRENTWOOD TENNESSEE 37027
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Digital and Tech Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/10/2026M1,400A$4.8111,119D
Common Stock06/10/2026S1,400D$15.2314(1)109,719D
Common Stock06/11/2026M33,600A$4.8143,319D
Common Stock06/11/2026S33,600D$14.4714(2)109,719D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$4.806/10/2026M1,400 (3)06/23/2027Common Stock1,400$033,600D
Stock Option (right to buy)$4.806/11/2026M33,600 (3)06/23/2027Common Stock33,600$00D
Explanation of Responses:
1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.20 to $15.26, inclusive.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.33 to $14.615, inclusive.
3. 1/12 of options vested on the 23rd of each month for twelve months beginning July 23, 2017.
Remarks:
The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form.
/s/ Edward J. Zecchini06/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Cryoport (CYRX) report for Edward Zecchini?

Cryoport reported that Chief Digital and Tech Officer Edward Zecchini exercised options for 35,000 common shares at $4.80 and sold 35,000 shares in open-market transactions at weighted average prices near $15.23 and $14.47 over two days.

How many Cryoport (CYRX) shares did Edward Zecchini sell and at what prices?

Edward Zecchini sold a total of 35,000 Cryoport common shares. He sold 1,400 shares at a weighted average price of about $15.23 and 33,600 shares at a weighted average price of about $14.47, across multiple trades within narrow price ranges.

What stock options did Edward Zecchini exercise in the latest Cryoport (CYRX) Form 4?

Zecchini exercised stock options labeled as a “Stock Option (right to buy)” covering 35,000 underlying common shares. The options had an exercise price of $4.80 per share and an expiration date of June 23, 2027, and this grant is now fully exercised.

How many Cryoport (CYRX) shares does Edward Zecchini hold after these transactions?

Following the reported option exercises and share sales, Edward Zecchini directly holds 109,719 shares of Cryoport common stock. This figure reflects his remaining equity position after exercising 35,000 options and selling 35,000 shares in the open market.

Was the Cryoport (CYRX) insider activity primarily a buy or sell event?

The activity was primarily a net-sell event. Zecchini exercised options to acquire 35,000 shares at $4.80 per share and sold 35,000 shares in open-market transactions, with the filing’s summary showing 35,000 shares sold and a net-sell share direction.